Clinical Research Directory
Browse clinical research sites, groups, and studies.
Dietary Restriction to Prevent Cardiotoxicity in Breast Cancer Patients
Sponsor: Erasmus Medical Center
Summary
The goal of this clinical trial is to compare a dietary intervention with a regular diet in patients with early breast cancer undergoing anthracycline based chemotherapy. The main question it aims to answer is: What are the effects of a short-term diet with 30% caloric and 70% protein restriction (PCR) on cardiotoxicity induced by anthracycline treatment in women with newly diagnosed invasive breast cancer. Researchers will compare the control group with dietary intervention group to see if cardiotoxicity -measured by concentrations of high-sensitivity troponin T (hsTnT) levels- will be different between these two groups.
Official title: Protein and Calorie Restriction as Treatment for Prevention of Cardiotoxicity in Women Receiving Chemotherapy.
Key Details
Gender
FEMALE
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
32
Start Date
2023-05-10
Completion Date
2026-05
Last Updated
2024-10-02
Healthy Volunteers
No
Conditions
Interventions
Protein- and Calorie restriction
The intervention consists of 30% calorie and 70% protein restriction, based on their daily nutritional intake. The protein and calorie restriction will be given in the form of Scandishake from Nutricia. These are ready available and easy to tailor to the caloric and protein need of each individual study subject.
Locations (1)
Erasmus MC
Rotterdam, South Holland, Netherlands